Pharmacokinetics and pharmacodynamics of prasugrel in subjects with moderate liver disease.
Background and Objective: Prasugrel is a thienopyridine antiplatelet agent under investigation for the prevention of atherothrombotic events in patients with acute coronary syndrome who undergo percutaneous coronary intervention. Patients with chronic liver disease are among those in the target popu...
| Publicado en: | Journal of Clinical Pharmacy & Therapeutics Vol. 34; no. 5; pp. 575 - 584 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Wiley-Blackwell
Oct2009
|
| Acceso en línea: | Ver este registro en EBSCOhost |